S. A. Watkins

发表

Measurements of the performance of an acoustical calibration duct

S. A. Watkins, 1995 .

The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridines.

S. A. Watkins, M. Vieth, R. Campbell, 2004, Molecular cancer therapeutics.

Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluation.

S. A. Watkins, M. Vieth, R. Campbell, 2004, Bioorganic & medicinal chemistry letters.

Synthesis of 1,7-annulated indoles and their applications in the studies of cyclin dependent kinase inhibitors.

S. A. Watkins, C. D. Spencer, J. Dempsey, 2004, Bioorganic & medicinal chemistry letters.

Studies on cyclin-dependent kinase inhibitors: indolo-[2,3-a]pyrrolo[3,4-c]carbazoles versus bis-indolylmaleimides.

S. A. Watkins, C. D. Spencer, J. Dempsey, 2003, Bioorganic & medicinal chemistry letters.

Structure-based design of a new class of highly selective aminoimidazo[1,2-a]pyridine-based inhibitors of cyclin dependent kinases.

S. A. Watkins, D. Robertson, C. Hamdouchi, 2005, Bioorganic & medicinal chemistry letters.

1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitors.

S. A. Watkins, C. D. Spencer, N. Stamm, 2004, Bioorganic & medicinal chemistry letters.

1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitors.

S. A. Watkins, C. D. Spencer, N. Stamm, 2004, Bioorganic & medicinal chemistry letters.

Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1-CDK4 inhibitors.

S. A. Watkins, R. Campbell, J. Dempsey, 2003, Bioorganic & medicinal chemistry letters.

Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles.

S. A. Watkins, R. Campbell, J. Dempsey, 2003, Bioorganic & medicinal chemistry letters.

Synthesis of quinolinyl/isoquinolinyl[a]pyrrolo [3,4-c] carbazoles as cyclin D1/CDK4 inhibitors.

S. A. Watkins, B. Teicher, J. Dempsey, 2003, Bioorganic & medicinal chemistry letters.

Conditional transformation of rat embryo fibroblast cells by a cyclin D1-cdk4 fusion gene

S. A. Watkins, K. Houck, N. Stamm, 1999, Oncogene.

Retrovirus-mediated gene transfer in lungs of living fetal sheep.

S. A. Watkins, P. Robbins, K. Albertine, 1995, Gene therapy.

Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors.

S. A. Watkins, R. Campbell, B. Teicher, 2003, Journal of medicinal chemistry.

Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitors.

S. A. Watkins, R. Schultz, Faming Zhang, 2004, Bioorganic & medicinal chemistry letters.

Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.

S. A. Watkins, H. Brooks, J. Yingling, 2005, Biochemistry.